INIT.ST
Price:
$2.59
Market Cap:
$120.95M
Initiator Pharma A/S is a clinical-stage life sciences firm dedicated to discovering therapeutic solutions for critical unmet medical needs affecting the central and peripheral nervous systems. Its development pipeline features several clinical-phase compounds: IP2018, a monoamine reuptake inhibitor aimed at psychogenic erectile dysfunction; IPED2015, designed to address organic erectile dysfunction; and IPTN2021, an orphan drug candidate for severe neuropathic pain. Additionally, the company holds early-stage assets, including IPNP2015 for chronic pain management and IPDP2015 for depression. Established in 2016, Initiator Pharma A/S maintains its headquarters in Copenhagen, Denmark.
Industry
Biotechnology
IPO Date
2017-03-16
Stock Exchange
STO
Ticker
INIT.ST
According to Initiator Pharma A/S’s latest financial reports and current stock price. The company's current PE Ratio is -5.53. This represents a change of -35.96% compared to the average of -8.63 of the last 4 quarters.
The mean historical PE Ratio of Initiator Pharma A/S over the last ten years is -1555.52. The current -5.53 PE Ratio has changed -64.45% with respect to the historical average. Over the past ten years (40 quarters), INIT.ST's PE Ratio was at its highest in in the December 2023 quarter at 56.51. The PE Ratio was at its lowest in in the June 2016 quarter at -1196.85.
Average
-1555.52
Median
-10.44
Minimum
-15428.49
Maximum
-1.73
Discovering the peaks and valleys of Initiator Pharma A/S PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 306.87%
Maximum Annual PE Ratio = -1.73
Minimum Annual Increase = -99.87%
Minimum Annual PE Ratio = -15428.49
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -8.88 | -54.14% |
| 2024 | -19.37 | -99.87% |
| 2023 | -15428.49 | 306.87% |
| 2022 | -5.03 | -48.68% |
| 2021 | -9.79 | -11.71% |
| 2020 | -11.09 | -37.29% |
| 2019 | -17.69 | 198.84% |
| 2018 | -5.92 | 243.05% |
| 2017 | -1.73 | -96.35% |
The current PE Ratio of Initiator Pharma A/S (INIT.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5152.25
5-year avg
-3094.31
10-year avg
-1555.52
Initiator Pharma A/S’s PE Ratio is greater than Bio-Works Technologies AB (publ) (-65.20), less than Lipum AB (publ) (-4.26), less than IRLAB Therapeutics AB (publ) (-1.46), less than Isofol Medical AB (publ) (-3.36), less than Annexin Pharmaceuticals AB (-2.87), less than Karolinska Development AB (publ) (-0.34), greater than iZafe Group AB (-5.96), greater than SenzaGen AB (-11.45), less than Alzinova AB (publ) (-4.09), less than Clinical Laserthermia Systems AB (publ) (-1.36),
| Company | PE Ratio | Market cap |
|---|---|---|
| -65.20 | $269.88M | |
| -4.26 | $304.40M | |
| -1.46 | $128.75M | |
| -3.36 | $262.80M | |
| -2.87 | $90.65M | |
| -0.34 | $64.66M | |
| -5.96 | $138.85M | |
| -11.45 | $171.64M | |
| -4.09 | $109.63M | |
| -1.36 | $57.75M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Initiator Pharma A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Initiator Pharma A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Initiator Pharma A/S's PE Ratio?
How is the PE Ratio calculated for Initiator Pharma A/S (INIT.ST)?
What is the highest PE Ratio for Initiator Pharma A/S (INIT.ST)?
What is the 3-year average PE Ratio for Initiator Pharma A/S (INIT.ST)?
What is the 5-year average PE Ratio for Initiator Pharma A/S (INIT.ST)?
How does the current PE Ratio for Initiator Pharma A/S (INIT.ST) compare to its historical average?